Q-omics provides the consensus-scored RPS26P41 profile across patient tissues and cancer cell-line models. RPS26P41 expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, RPS26P41 is differentially expressed in 11, with the highest sampling consensus in THCA. Additionally, RPS26P41 RNA expression shows 11,994 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and THCA as cancer lineages where RPS26P41 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPS26P41 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPS26P41 survival associations across molecular data types. RPS26P41 RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPS26P41 RNA expression–survival associations across cancer types. High RPS26P41 expression shows unfavorable associations in UVM, THCA, LIHC, THYM and KIRC, but favorable associations in HNSC. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify UVM as the clearest survival context for RPS26P41 RNA expression.
This table summarizes RPS26P41 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RPS26P41. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPS26P41 shows lower tumor expression in THCA and KIRC and higher tumor expression in READ, ESCA, PRAD and CHOL. The THCA box plot shows higher RPS26P41 RNA expression in normal versus tumor tissue (log2 FC = −0.767, t-test p < 0.001).
This table shows molecular features associated with RPS26P41 in patient tissues and cancer cell lines. In patient samples, RPS26P41 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
